Brind.
  1. NRx Pharmaceuticals detailed plans for HOPE Therapeutics clinics launch, while Matthew Rockefeller joined the advisory board and Global Passion Project offered support.
  2. HOPE Therapeutics is closing the acquisition of Dura Medical, which operates clinics on Florida's west coast.

AHCA granted final clearance for the acquisition closing of Dura Medical by HOPE Therapeutics, which is a subsidiary of NRx Pharmaceuticals.

1 report, 1 independent Updated Aug 8
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

AHCA granted final clearance for the acquisition closing of Dura Medical by HOPE Therapeutics, which is a subsidiary of NRx Pharmaceuticals.

Who's involved

What this event is mainly about
Agency for Health Care Administration

Keep exploring

Part of

HOPE Therapeutics is closing the acquisition of Dura Medical, which operates clinics on Florida's west coast. All 1 developments

Within NRx Pharmaceuticals detailed plans for HOPE Therapeutics clinics launch, while Matthew Rockefeller joined the advisory board and Global Passion Project offered support.

The entities involved

Coverage

Newest first; wire copies grouped
  • PR NewswireHOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Receipt of Final Clearance to Proceed to Closing of Dura Medical Acquisition from Florida's Agency for Health Care Administ